Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) has announced a significant increase to its previously disclosed private placement of convertible debentures, raising the aggregate principal amount from $8.1 million to $21 million following strong investor interest. Alongside the upsized financing, the company has postponed its annual general and special meeting from September 16, 2026 to September 24, 2026, allowing shareholders additional time to review an amended management proxy circular. The changes reflect material updates to the financing terms and introduce a new placement agent arrangement. Investors in the plant-based protein company may be watching both shareholder approval progress and the planned closing timeline closely.

Key Points

  • Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF)
  • Non-brokered private placement of convertible debentures upsized from $8.1 million to $21 million after strong investor demand
  • Annual general and special meeting rescheduled to September 24, 2026; proxy deadline is 10 a.m. Pacific Time on September 22, 2026
  • TSX conditional approval received; shareholder approval required before closing can proceed

Burcon's $21 Million Convertible Debenture Upsize and Amended Terms

Burcon's board of directors unanimously approved increasing the private placement of convertible debentures to $21,000,000 from the originally announced $8,100,000. The release states that insider participation in the upsized financing remains the same as previously disclosed. One notable change to the terms is the replacement of a prepaying right with an accelerated conversion right, which allows Burcon, at its sole discretion, to require holders to convert all outstanding principal at the conversion price. This right may be exercised after the daily volume weighted average trading price of common shares on the TSX equals or exceeds $3.20 for any 14 consecutive trading days, with 15 days' advance written notice required.

Benchmark Company Engaged as Exclusive Placement Agent

Burcon has engaged The Benchmark Company, LLC, headquartered in New York, as exclusive placement agent for the upsized private placement on a best-efforts basis. Under the arrangement, Benchmark will receive a cash fee of 5% of gross proceeds from a specified existing arm's-length shareholder and its affiliates, and 8% of gross proceeds from all other participating investors. The release states no fee will be payable on proceeds invested by Burcon's management, board of directors, or other insiders. The company intends to close the financing in one or more tranches following receipt of the required shareholder approvals.

Planned Use of Net Proceeds Across Operations and Debt Reduction

Burcon outlined several intended uses for net proceeds from the upsized placement, including investments in inventory, labour, production capability, and infrastructure expansion at its Galesburg, Illinois facility. The company also cited plans to improve production efficiency, strengthen organisational structure, and partially repay a senior secured loan from Large Scale Investments Limited, an entity related to director Alan Chan. Reduction of short-term insider debt and general working capital requirements were also listed. The board stated it believes the additional capital will help accelerate the company's growth plans.

Shareholders Directed to Updated Meeting Materials and New Voting Forms

Burcon has instructed shareholders to disregard any previously received proxy or voting instruction forms related to the September 16, 2026 meeting and to use the new materials distributed in connection with the rescheduled September 24, 2026 AGSM. The amended and restated management proxy circular, dated September 4, 2026, supersedes the original circular dated July 31, 2026. Proxies must be received no later than 10 a.m. Pacific Time on September 22, 2026. Meeting materials are available on the company's website. The upsized private placement has received conditional TSX approval, subject to shareholder approval and compliance with TSX conditions.